Vulvar carcinoma
MONDO:0005215A carcinoma that arises from epithelial cells of the mammalian vulva
Also known as: cancer of the vulva, cancer of vulva, vulva cancer, vulvar cancer, carcinoma of mammalian vulva, carcinoma of the vulva, carcinoma of vulva, mammalian vulva carcinoma
2888 clinical trials for this condition and its sub-types, 24 tagged with Vulvar carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Vulvar carcinoma
-
Vulvar squamous cell carcinoma 22 trials
6 sub-types
- Bartholin gland squamous cell carcinoma 0 trials Sub-types →
- Vulva verrucous carcinoma 0 trials
- Vulvar basaloid squamous cell carcinoma 0 trials
- Vulvar keratinizing squamous cell carcinoma 0 trials
- Vulvar keratoacanthoma-like carcinoma 0 trials
- Vulvar non-keratinizing squamous cell carcinoma 0 trials
-
Vulvar adenocarcinoma 3 trials · 5 incl. sub-types
7 sub-types
- Vulval Paget disease 2 trials
- Bartholin gland adenocarcinoma 0 trials Sub-types →
- Adenocarcinoma of skene gland origin 0 trials
- Vulvar apocrine adenocarcinoma 0 trials
- Vulvar clear cell hidradenocarcinoma 0 trials
- Vulvar eccrine adenocarcinoma 0 trials Sub-types →
- Vulvar sebaceous carcinoma 0 trials
-
Bartholin gland carcinoma 0 trials · 1 incl. sub-types
4 sub-types
-
Clitoral carcinoma 0 trials
-
Labia majora carcinoma 0 trials
-
Labia minora carcinoma 0 trials
-
Vulva basal cell carcinoma 0 trials
-
Vulvar neuroendocrine carcinoma 0 trials
1 sub-type
- Bartholin gland small cell carcinoma 0 trials
-
Vulvar seborrheic keratosis 0 trials
1 sub-type
- Vulvar inverted follicular keratosis 0 trials
Most studied deeper sub-types
-
Targeted drug shows promise for rare vulvar cancer
Disease control Not yet recruitingThis phase 2 trial tests a drug called tisotumab vedotin in people with advanced squamous cell carcinoma of the vulva that has returned or spread. The drug is an antibody-drug conjugate designed to seek out and destroy cancer cells. The study aims to see how many participants' tu…
Phase 2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Vulvar cancer study aims to spare women from unnecessary surgery
Disease control Not yet recruitingThis study tests whether regular ultrasound checks of the groin can safely replace the standard surgery to remove lymph nodes in women with early-stage vulvar cancer. The goal is to reduce side effects and improve recovery while still keeping the cancer under control. About 640 w…
Phase 3 • Sponsor: Queensland Centre for Gynaecological Cancer • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study explores combining cancer and blood vessel surgery for advanced gynecologic tumors
Knowledge-focused Not yet recruitingThis study looks at how well patients do after surgery that removes both advanced gynecologic cancers and the major blood vessels they have grown into. Researchers will track 130 participants for up to 5 years to see survival rates and how long it takes for the cancer to return. …
Sponsor: National Cancer Institute, Naples • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC